Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

David Russell‐Jones; Arnaud Dauchy; Elías Delgado; George Dimitriadis; Hans A. Frandsen; Luiza Popescu; Bernd Schultes; Krzysztof Strojek; Mireille Bonnemaire; Aude Roborel de Climens; Melanie Davies

doi:10.1111/dom.13697

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13697 ◽

2019 ◽

Vol 21 (7) ◽

pp. 1615-1624 ◽

Cited By ~ 3

Author(s):

David Russell‐Jones ◽

Arnaud Dauchy ◽

Elías Delgado ◽

George Dimitriadis ◽

Hans A. Frandsen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Efficacy And Safety

Download Full-text

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial

Diabetes Care ◽

10.2337/dc16-0046 ◽

2016 ◽

Vol 39 (9) ◽

pp. 1579-1586 ◽

Cited By ~ 51

Author(s):

Julio Rosenstock ◽

Michaela Diamant ◽

Vanita R. Aroda ◽

Louise Silvestre ◽

Elisabeth Souhami ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Fixed Ratio ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Metformin Monotherapy

Download Full-text

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980

Diabetes Care ◽

10.2337/dc17-er06d ◽

2017 ◽

Vol 40 (6) ◽

pp. 809.2-809

Author(s):

Vanita R. Aroda ◽

Julio Rosenstock ◽

Carol Wysham ◽

Jeffrey Unger ◽

Diego Bellido ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Diabetes Care ◽

Basal Insulin ◽

Fixed Ratio ◽

Efficacy And Safety

Download Full-text

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial

Diabetes Care ◽

10.2337/dc16-1495 ◽

2016 ◽

Vol 39 (11) ◽

pp. 1972-1980 ◽

Cited By ~ 104

Author(s):

Vanita R. Aroda ◽

Julio Rosenstock ◽

Carol Wysham ◽

Jeffrey Unger ◽

Diego Bellido ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Basal Insulin ◽

Fixed Ratio ◽

Efficacy And Safety

Download Full-text

Exenatide Versus Insulin Glargine in Patients With Suboptimally Controlled Type 2 Diabetes: A Randomized Trial

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70285-3 ◽

2006 ◽

Vol 2006 ◽

pp. 56-61

Author(s):

J.L. Leahy ◽

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial

Download Full-text

The efficacy and safety of LY2963016 among patients with Type 1 and Type 2 diabetes previously treated with insulin glargine

Diabetologie und Stoffwechsel ◽

10.1055/s-0035-1549538 ◽

2015 ◽

Vol 10 (S 01) ◽

Author(s):

D Dahl ◽

LB Lacaya ◽

RK Pollom ◽

LL Ilag ◽

JS Zielonka

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Efficacy And Safety ◽

Previously Treated

Download Full-text

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2014.08.003 ◽

2014 ◽

Vol 106 (2) ◽

pp. 264-274 ◽

Cited By ~ 27

Author(s):

David R. Owens ◽

Louise Traylor ◽

Marie-Paule Dain ◽

Wolfgang Landgraf

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Randomised Controlled Trials ◽

Pooled Analysis ◽

Treat To Target ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomised Controlled

Download Full-text

Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2012.11.043 ◽

2013 ◽

Vol 61 (4) ◽

pp. 579-587 ◽

Cited By ~ 77

Author(s):

Juan C. Arjona Ferreira ◽

Dalila Corry ◽

Carl E. Mogensen ◽

Lance Sloan ◽

Lei Xu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Efficacy And Safety

Download Full-text

Decision letter for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

Review for "Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Glargine 100 U/mL in Asia Pacific Insulin‐Naïve People with Type 2 Diabetes: The EDITION AP Randomised Controlled Trial"

10.1111/dom.13936/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Controlled Trial ◽

Insulin Glargine ◽

Controlled Trial ◽

Asia Pacific ◽

Efficacy And Safety ◽

Randomised Controlled

Download Full-text